To defend Trump, Republicans scoff at ‘process

New Post Public Reply Private Reply Replies (1) Message Board

Jan 31, 2019 at 8:33 PM 121

Quote:

To defend Trump, Republicans scoff at ‘process crimes’

11/30/18 09:20 AM—Updated 11/30/18 09:49 AM

Quote:

Second, I seem to recall Lindsey Graham serving as an impeachment manager 20 years ago against a sitting president accused of perjury. It suggests the Republican lawmaker’s indifference toward “process crimes” is fairly new.

Quote:

“Your right-wing uncle, who’d never encountered the phrase ‘process crime’ until today, will be tossing it around by the weekend as if he’s been talking about process crimes all his adult life.”

By Steve Benen

Yesterday was not a good day for Donald Trump. The president’s former personal attorney and “fixer” pleaded guilty in a federal courtroom, admitting that he lied to Congress about Trump’s efforts to build a Trump Tower in Moscow.

It marked the first time the president’s private business dealings in Moscow were directly implicated in Special Counsel Robert Mueller’s investigation into the broader Russia scandal.

If the president’s Republican allies were going to defend him from developments like these, they’d need to get creative. Evidently, they came up with a new thing at which to scoff: “process crimes.”

Some Republicans, like Sen. Lindsey Graham of South Carolina and Sen. John Thune of South Dakota, said Cohen’s admission doesn’t prove collusion between Russia and the president. […]

Graham, who has emerged as one of Trump’s fiercest defenders, said he had “no idea what that’s all about” when asked his reaction to Cohen’s guilty plea, adding that it “seems to be a process crime.”

Soon after, Rush Limbaugh complained, “Every one of Mueller’s indictments is a process crime.”

As TPM reported, Michael Anton, former spokesman for Trump’s National Security Council, also lashed out at Mueller’s team for pursuing a “process” crime.

Putting aside the amazing coincidence of these Republicans coming up with the same rhetorical line on the same afternoon, it’s worth pausing to understand what in the world these guys are talking about.

There are legal experts who can speak to this with far more authority than I can, but as I understand it, a “process crime” refers to wrongdoing related to an investigation into a crime, rather than the crime itself.

For example, let’s say you were suspected of robbing a bank. During the police investigation, you lied about your whereabouts during the robbery, encouraged others to give false testimony, and destroyed relevant evidence. As a result, you were then charged with perjury and obstruction of justice.

Those would be “process crimes,” unrelated to possible charges about the bank robbery itself.

For Trump’s followers, this has apparently become a life-preserver worth clinging to. Trump’s lawyer lied to Congress under oath about the proposed Trump Tower Moscow project, but to hear Lindsey Graham and his cohorts tell it, that’s not worth making a fuss about.

We’d all be better off waiting, the argument goes, to see if Mueller brings collusion-related charges – which he hasn’t done.

There are, of course, a few problems with such a posture. The first is, when a president’s partisan followers are reduced to scoffing at the significance of felonies, they’re not standing on firm ground.

Second, I seem to recall Lindsey Graham serving as an impeachment manager 20 years ago against a sitting president accused of perjury. It suggests the Republican lawmaker’s indifference toward “process crimes” is fairly new.

And third, there’s no reason to assume the special counsel and his team are done. Criminal charges related to the “process” today may very well lead to an entirely different set of criminal charges tomorrow.

Postscript: Steve at No More Mister Nice Blog joked yesterday, “Your right-wing uncle, who’d never encountered the phrase ‘process crime’ until today, will be tossing it around by the weekend as if he’s been talking about process crimes all his adult life.”

http://www.msnbc.com/rachel-maddow-show/defen...ess-crimes

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Vertiv's SmartIT: The New AI Infrastructure Game-Changer

Taking AI Infrastructure Up a Notch Vertiv Holdings Co. (NYSE: VRT) is charging ahead with a solution that's bound to rattle the cages of status quo infrastructure deployments. Say hello to Vertiv™ SmartIT, a finely-tuned piece of kit that's pre-engineered to ease up the often painful process of high-density AI deployments across various environments—from homey...

Custom Concrete: Crafting the Perfect Poolside Paradise

Concrete: The Unsung Hero of Your Pool's Success You know, everyone always raves about that sparkling pool, but let's be real—it's the concrete holding the whole gig together. James White from White's Pools in Loganville, GA, drops some knowledge in a recent HelloNation piece about the unsung hero of backyard oases: custom concrete. Yeah, it's not sexy, but when you're...

Better Home & Finance Faces 28.5% Stock Plunge, Lawsuit

The Sudden Dive in Better Home's Stock Imagine cruising down the highway with the wind in your hair and suddenly slamming into a pothole. That's the kind of jarring experience Better Home & Finance Holding Company (NASDAQ: BETR) investors felt when the stock took a nosedive, diving a hefty 28.5%. Back on May 7, 2026, the company released financial figures that flipped the...

Cumberland Pharmaceuticals Eyes NDA for Ifetroban in DMD

Rolling the Dice with Ifetroban There's a buzz in the air around Cumberland Pharmaceuticals as they gear up to tackle one of medicine's stubborn giants, Duchenne muscular dystrophy (DMD). They plan to file a New Drug Application (NDA) with the FDA for ifetroban, aiming to treat the cardiomyopathy plaguing many DMD sufferers. Folks who’ve watched Cumberland (NASDAQ:CPIX)...

Federal Law Shifts Landscape for Manufactured Housing

Federal Act Aims to Boost Manufactured Homes Price tags on homes need a reality check, and for a long time, manufactured housing has been in the corner looking for a chance to throw its hat in the ring. Enter the 21st Century ROAD to Housing Act, aiming to finally unlock the potential sitting in our backyards when it comes to these factory-built options. We're talking...

Gildan Activewear Faces Major Class Action Lawsuit

Investors Turn Against Gildan Activewear Ever see a freight train barreling down the track? That's what it feels like when a class action lawsuit rears its head against a behemoth like Gildan Activewear Inc. (NYSE: GIL). After years of allegedly pulling the wool over investors' eyes, those same investors are now being called to muster—their chance to lead a charge of...

Temu Partners with Recyclia to Drive EPR Compliance Boost

Temu and Recyclia: Building a Sustainable Marketplace Get this: Temu, the e-commerce giant you've heard trumpeting about affordable goods like some digital bazaar, is diving deeper into sustainability waters with a partner that knows a thing or two about waste. This time, they've linked up with Recyclia over in Spain. The duo's focus? Helping marketplace sellers meet the...

3TREES Debuts Green Coatings to East African Market

3TREES Rocks East Africa's Construction Scene Nairobi's got a spark this week, and it's radiating straight from 3TREES' corner at the Big 5 Construct Kenya. With the Sarit Expo Centre buzzing from October 21, 2026, this Chinese company didn't just show up—they made one hell of an entrance. Presenting eco-friendly coating solutions, they pushed the 'Create Healthy Life'...

Superteam Wheels Rides Into Spain with RACEIT Deal

Rolling Out the Red Carpet for Spanish Cyclists Think of it as the pedal-powered bridge from wherever Superteam Wheels calls home to the sunny streets of Spain. If you're in the cycling game, this new partnership between Superteam Wheels and COMERTECH RACEIT, S.L., better known as RACEIT, is drawing a line in the sand—or perhaps on the asphalt—across Europe. Starting...

Sintilimab Poised for New Milestone in Melanoma Fight

An Opening Shot: NMPA's Decision Window Well, here's the latest chapter in the saga of battling advanced melanoma with some real gritty numbers behind it. Innovent Biologics has thrown its hat back in the ring with news that the China National Medical Products Administration (NMPA) has embraced a new indication application for their drug sintilimab. They're teaming it up...